BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 23, 2019
View Archived Issues
Hormonal obesity promoter identified
Read More
Drugs blocking "hugs" could fight fibrosis
Read More
Kinases and chemo
Read More
Results from dose-selection trial of H56:IC31 vaccine candidate in tuberculosis-endemic populations
Read More
Fever directs traffic to strengthen immune response
Read More
Blincyto approved for expanded indication in Europe
Read More
I-Mab receives FDA IND clearance for phase I study of TJD-5
Read More
Rocket Pharmaceuticals announces FDA clearance of IND for RPA-501 gene therapy
Read More
Voclosporin ophthalmic solution demonstrates statistically superior efficacy versus Restasis
Read More
Margetuximab plus pembrolizumab shows promising activity in HER2+ (IHC3+) gastric carcinoma
Read More
Ramucirumab plus nivolumab shows promising antitumor activity in phase I/II NivoRam study
Read More
KemPharm presents phase I data for KP-415
Read More
Daiichi Sankyo presents phase I data for DS-8895a in patients with solid tumors
Read More
SM-88 appears safe and active in phase II trial in metastatic pancreatic adenocarcinoma
Read More
Sorrento reports phase Ib interim analysis with resiniferatoxin in knee osteoarthritis pain
Read More
Esteve Pharmaceuticals presents new analgesics
Read More
AstraZeneca divulges new SERDs
Read More
Phase III study of NexoBrid meets primary and secondary endpoints
Read More
Bio-Thera begins phase III study of tocilizumab biosimilar BAT-1806
Read More
Beijing Foreland Pharma identifies lysophospholipid S1P1 receptor ligands
Read More
Ultragenyx reports long-term extension study results for UX-007 in LC-FAOD
Read More
New PRMT5 inhibitors presented by Bayer
Read More
Shenzhen Targetrx Biotechnology patents EGFR double-mutant inhibitors
Read More
PROLONG study of OBE-022 in preterm labor advances into part B following successful part A
Read More
